Celltrion Pharm, Inc.

Celltrion Pharm, Inc.

Share · KR7068760008 (XKOS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Celltrion Pharm, Inc.
No Price
Closing Price XKOS 29.04.2026: 57.700,00 KRW
29.04.2026 05:34
Current Prices from Celltrion Pharm, Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
XKOS: KOSDAQ
KOSDAQ
068760.KQ
KRW
29.04.2026 05:34
57.700,00 KRW
-200,00 KRW
-0,35 %
Share Float & Liquidity
Free Float 44,51 %
Shares Float 19,72 M
Shares Outstanding 44,29 M
Invested Funds

The following funds have invested in Celltrion Pharm, Inc.:

Fund
iShares MSCI Korea UCITS ETF (Dist)
Vol. in million
1.533,11
Percentage (%)
0,24 %
Fund
iShares MSCI Korea UCITS ETF USD (Acc)
Vol. in million
414,31
Percentage (%)
0,23 %
Fund
iShares MSCI EM ex-China UCITS ETF USD (Acc)
Vol. in million
7,83
Percentage (%)
0,05 %
Fund
iShares MSCI AC Far East ex-Japan UCITS ETF USD (Acc)
Vol. in million
7,85
Percentage (%)
0,04 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Dist)
Vol. in million
87,03
Percentage (%)
0,03 %
Company Profile for Celltrion Pharm, Inc. Share
Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju, South Korea.

Company Data

Name Celltrion Pharm, Inc.
Company Celltrion Pharm, Inc.
Website https://www.celltrionph.com
Primary Exchange XKOS KOSDAQ
ISIN KR7068760008
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Yoo Young-Ho
Market Capitalization 2.565 Mrd.
Country South Korea
Currency KRW
Employees 0,9 T
Address 82, 2sandan-ro, Cheongju
IPO Date 2006-02-03
Dividends from 'Celltrion Pharm, Inc.'
Ex-Date Dividend per Share
29.12.2025 200,00 KRW
27.12.2006 111,05 KRW

Stock Splits

Date Split
29.12.2025 51:50
27.12.2024 21:20
27.12.2023 21:20
28.12.2022 21:20
29.12.2021 103:105
29.12.2020 680:721
27.12.2019 5000:5253
27.12.2017 1020000:1158287
28.12.2016 262500:295363
29.12.2015 41200:49621
29.12.2014 1050000:1277741

Ticker Symbols

Name Symbol
KOSDAQ 068760.KQ
More Shares
Investors who hold Celltrion Pharm, Inc. also have the following shares in their portfolio:
INTELSAT LUX. 18/23 REGS
INTELSAT LUX. 18/23 REGS Bond
Zhejiang Kan Specialities Material Co., Ltd.
Zhejiang Kan Specialities Material Co., Ltd. Share